allcancercure.com

Bone Medical Limited (ASX:BNE) announced that patients have received their first doses in the oral CaPTHymone(PTH) Phase I/II clinical trial carried out at Q-Pharm, Brisbane, Australia. Eight female volunteers will be dosed at two different times and the results will help Bone choose between two different versions of the in-licensed Axcess™ oral delivery technology and [...]

Covalon Technologies Ltd. (the “Corporation” or “Covalon”) (TSX VENTURE: COV) is pleased to announce that the Orthopaedic Trauma Association (OTA), the premier international organization for orthopaedic trauma surgeons, has announced grant funding for a study titled “Efficacy and Safety of Covalent Bonding of Silver to Orthopedic Trauma Hardware: Investigation of a Novel Coating Technology”. This [...]

Women with osteoarthritis of the knee wait longer than men before pursuing knee replacement surgery, according to a study published in the November 2007 issue of The Journal of Bone and Joint Surgery. This delay in treatment may result in poorer post-operative outcomes for female patients. More than 300,000 total knee replacements (also known as [...]

Genta Incorporated (Nasdaq: GNTA) released findings from the initial clinical dosing of G4544, the Company’s proprietary small molecule that is intended as a treatment for diseases associated with accelerated bone loss. The Phase 1 study, which was conducted in normal volunteers, has shown good tolerance with oral bioavailability of the active ingredient, and an excellent [...]

Ten million people in the United States are estimated to already have bone diseases, and almost 34 million more are estimated to have low bone mass, putting them at increased risk for osteoporosis, according to the National Osteoporosis Foundation. Liyun Wang, assistant professor of mechanical engineering at the University of Delaware, knows the serious consequences [...]